Defiance 2X Long and 2X Short Daily Anthropic ETFs, ANTC and ANTQ, Begin Trading Monday, Nov. 23

Defiance ETFs launched two leveraged ETFs, ANTC (long) and ANTQ (short), tied to Anthropic (ANT) stock, starting trading on Nasdaq on Nov. 23, 2026. Both ETFs aim for 200% daily returns, with 0.71% expense ratios. Anthropic, an AI company, began trading on Nov. 19, 2026, raising $93.5B in its IPO.

Original reporting
Published Nov 22, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 22, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Defiance 2X Long and 2X Short Daily Anthropic ETFs, ANTC and ANTQ, Begin Trading Monday, Nov. 23 — source image
Decision brief

The 30-second read

$ANTNeutralMed
01

Why it matters

The key tradable change is the first day of trading and the explicit daily 2X/-2X objective tied to ANT’s close-to-close daily percentage change, which implies reset and compounding effects for any holding beyond one day.

02

Market read

Traders get a new, exchange-listed way to express short-term directional views on ANT with daily 2X leverage, starting at a specific time.

03

What to watch

The 0.71% expense ratio plus swap costs and the compounding/volatility drag can deter holding periods, so early trading may be driven more by day-traders than by longer-term allocators.

Relevance 6/10Novelty 7/10Timing: Starts trading Monday, Nov. 23 at the 9:30 a.m. ET open; shares cannot be purchased before then.

Background

Defiance ETFs announced two newly launched leveraged single-stock ETFs tied to Anthropic (ANT): a 2X daily long (ANTC) and a 2X daily inverse short (ANTQ).

Company-level read

Ticker impact

$ANTNeutralMedium confidence
Context

The ETFs are tied to Anthropic’s share price (ANT), whose Nasdaq trading began Nov. 19, 2026.

Expected impact

Potential for amplified short-term price action in ANT as traders use ANTC/ANTQ for daily directional bets and hedges.

Evidence & confidence

The article does not claim a direct flow or impact on ANT’s price, but the launch of 2X long and inverse products can mechanically increase attention and trading around daily moves.

Market effects

Adds new leveraged single-stock ETF wrappers tied to an AI listing, potentially increasing retail and short-term trader participation in AI-related equities.

US-focused, as the funds list on Nasdaq and trade via standard brokerage accounts.

Limited global spillover expected; impact is mainly within US ETF and single-stock trading ecosystems.

Counterpoint

Because these are daily-reset 2X products, longer-horizon investors may avoid them, limiting sustained demand beyond the first-session setup.

Key entities

  • Defiance ETFs

    Sponsor of the ANTC and ANTQ leveraged single-stock ETFs.

  • ANTC

    Defiance 2X ANT Long Daily ETF, begins trading Nov. 23 at 9:30 a.m. ET.

  • ANTQ

    Defiance 2X ANT Short Daily ETF, begins trading Nov. 23 at 9:30 a.m. ET.

  • Anthropic

    AI company behind Claude; its Nasdaq-listed shares (ANT) began trading Nov. 19, 2026 and serve as the reference for both ETFs.

Related articles

$TSMMed

Export boom sends Q3 surplus soaring

Taiwan's Q3 current account surplus hit US$68.79B, driven by record exports of US$225.8B, largely due to AI-related demand. TSMC acquired a 0.03% stake in AI firm Anthropic for US$500M. Lam Research and SPIL announced expansions to support AI infrastructure. TSMC tightened restrictions on Chinese chip designers, limiting access to advanced tech.

$ANTMed

Anthropic Stock $88.91: 5 Analyst Targets Average $134

Anthropic's stock closed at $88.91 on Friday, down 8.5% from its debut. Analysts set targets averaging $134, with Melius Research highest at $155. Seaport Research rated it Neutral. The stock is 7.1% above its IPO price. Underwriters' research is expected after a 10-day quiet period.

$ANTHighAI 8/10

Anthropic rings the Nasdaq bell and then solves Riemann Hypothesis, what next now?

Anthropic (ANT) debuted on Nasdaq with a $1.5T market cap, briefly surpassing $2T before a selloff. The company aims to focus on institutional AI applications, particularly in medicine, and claims to have solved the Riemann Hypothesis. However, it faces challenges in justifying its valuation, with projected 2026 revenue of $45B falling short of the $600B needed for 20% returns on $1T AI investment. Sarvam, an Indian AI company, pivoted to offering inference services, sparking debate.

$ANTHighAI 8/10

How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

Anthropic (ANT) priced its IPO at $83.00 per share, raising $81.3 billion, and began trading on Nasdaq at $111.50. Leverage Shares by Themes plans to launch ANUU, a 2X leveraged ETF tracking ANT, on November 23, 2026. The ETF is designed for active traders seeking daily 2X exposure to Anthropic's stock performance, with an expense ratio of 0.75%.

$ANTMed

[IT Times Weekly] Anthropic’s $93.5B Nasdaq Debut and Factory Humanoids Signal AI’s Industrial Era

Anthropic debuted on Nasdaq at $83/share, raising $93.5B (total $119.5B incl. private placement). Microsoft's AI security initiative flagged 9,791 vulnerabilities. Boston Dynamics' humanoid Atlas to trial in semiconductor fabs. Hyundai launched Avante with AI infotainment. Tether invested in SCRYPT for institutional crypto services. POSCO secured 3-year lithium supply deal with CATL.